Guidelines for State Health Society and District Health Society
Reach the Unreached - FIND, TREAT, CURE TB, SAVE LIVES
The purpose of adding the books to the website of MCAI for download, is to make this life-saving, up-to-date information available to all who need it. Fill in a short registration field and you can download the pdf-files.
If you work in a hospital in a low income country - providing free care - y...ou are probably intitled to FREE copies of these books. MCAI will send them to you, all you have to do is to read our Flyer and fill in the request form.
more
Translation provided of the German Asylum Procedure Act (Asylverfahrensgesetz) by the Language Service of the Federal Ministry of the Interior. The translation includes the amendment(s) to the Act by Article 2 of the Act of
23.12.2014 (Federal Law Gazette I p. 2439). BEWARE: This version does no...t include the amendment of Nov. 2011! To compare with the current status of the German version, see http://www.gesetze-im-internet.de/asylvfg_1992/BJNR111260992.html.
more
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I...ndia, which supplies most of the antimicrobials consumed in Europe. In a briefing detailing the pollution, the EPHA urges major purchasers of antibiotics to blacklist irresponsible pharmaceutical companies, demand that the industry clean up its supply chain, introduce greater transparency on the origin of antibiotics, and review and revise procurement policies from an ethics perspective.
more
Strengthening Parmaceutical Systems. 2nd edition
The ICAT is a simple and practical approach for assessing the adequacy of existing infection prevention and control practices and provides specific recommendations for improving practices and monitoring their effectiveness over time
Prices people pay for medicines.
This document presents a strategic framework, aimed towards the development of sustainable global, regional and national plans relating to laboratory biorisk management.